NeuroPace (NPCE) Accumulated Expenses (2020 - 2026)

NeuroPace's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $9.3 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 15.96% year-over-year to $9.3 million; the TTM figure through Mar 2026 stood at $9.3 million (up 15.96% YoY), while the FY2025 annual figure was $13.3 million, up 36.29% from the prior year.
• Accumulated Expenses was $9.3 million for Q1 2026 at NeuroPace, down from $13.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $13.3 million in Q4 2025 to a low of $6.6 million in Q1 2023.
• Historically, Accumulated Expenses has averaged $9.0 million across 5 years, with a median of $8.2 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Accumulated Expenses surged 87.73% in 2022, then decreased 12.46% in 2024.
• A 5-year view of Accumulated Expenses shows it stood at $7.4 million in 2022, then surged by 50.8% to $11.2 million in 2023, then dropped by 12.46% to $9.8 million in 2024, then soared by 36.29% to $13.3 million in 2025, then declined by 29.95% to $9.3 million in 2026.
• The last three Accumulated Expenses figures came in at $9.3 million (Q1 2026), $13.3 million (Q4 2025), and $12.3 million (Q3 2025), per Business Quant data.